54 related articles for article (PubMed ID: 9342770)
1. Hypericin as a promising natural bioactive naphthodianthrone: A review of its pharmacology, pharmacokinetics, toxicity, and safety.
Peng Z; Lu J; Liu K; Xie L; Wang Y; Cai C; Yang D; Xi J; Yan C; Li X; Shi M
Phytother Res; 2023 Dec; 37(12):5639-5656. PubMed ID: 37690821
[TBL] [Abstract][Full Text] [Related]
2. Biological Evaluation of
Marcucci C; Rademacher M; Kamecki F; Pastore V; Bach HG; Ricco RA; Wagner ML; Knez D; Gobec S; Colettis N; Marder M
Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678626
[TBL] [Abstract][Full Text] [Related]
3. Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction.
Auxtero MD; Chalante S; Abade MR; Jorge R; Fernandes AI
Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33478035
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of St. John's wort drug interactions revisited.
Nicolussi S; Drewe J; Butterweck V; Meyer Zu Schwabedissen HE
Br J Pharmacol; 2020 Mar; 177(6):1212-1226. PubMed ID: 31742659
[TBL] [Abstract][Full Text] [Related]
5. Hypericin maintians PDX1 expression via the Erk pathway and protects islet β-cells against glucotoxicity and lipotoxicity.
Liang C; Hao F; Yao X; Qiu Y; Liu L; Wang S; Yu C; Song Z; Bao Y; Yi J; Huang Y; Wu Y; Zheng L; Sun Y; Wang G; Yang X; Yang S; Sun L; Li Y
Int J Biol Sci; 2019; 15(7):1472-1487. PubMed ID: 31337977
[TBL] [Abstract][Full Text] [Related]
6. Cordycepin Increases Nonrapid Eye Movement Sleep via Adenosine Receptors in Rats.
Hu Z; Lee CI; Shah VK; Oh EH; Han JY; Bae JR; Lee K; Chong MS; Hong JT; Oh KW
Evid Based Complement Alternat Med; 2013; 2013():840134. PubMed ID: 23710239
[TBL] [Abstract][Full Text] [Related]
7. Hypericum perforatum L. subsp. perforatum induces inhibition of free radicals and enhanced phototoxicity in human melanoma cells under ultraviolet light.
Menichini G; Alfano C; Marrelli M; Toniolo C; Provenzano E; Statti GA; Nicoletti M; Menichini F; Conforti F
Cell Prolif; 2013 Apr; 46(2):193-202. PubMed ID: 23510474
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.
Sacher J; Houle S; Parkes J; Rusjan P; Sagrati S; Wilson AA; Meyer JH
J Psychiatry Neurosci; 2011 Nov; 36(6):375-82. PubMed ID: 21463543
[TBL] [Abstract][Full Text] [Related]
9. Mania and Psychosis Associated with St. John's Wort and Ginseng.
Joshi KG; Faubion MD
Psychiatry (Edgmont); 2005 Sep; 2(9):56-61. PubMed ID: 21120109
[TBL] [Abstract][Full Text] [Related]
10. Hypericins as potential leads for new therapeutics.
Karioti A; Bilia AR
Int J Mol Sci; 2010 Feb; 11(2):562-94. PubMed ID: 20386655
[TBL] [Abstract][Full Text] [Related]
11. St. John's wort: role of active compounds for its mechanism of action and efficacy.
Butterweck V; Schmidt M
Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987
[TBL] [Abstract][Full Text] [Related]
12. Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients.
Wurglics M; Schubert-Zsilavecz M
Clin Pharmacokinet; 2006; 45(5):449-68. PubMed ID: 16640452
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of St John's wort in depression : what is known?
Butterweck V
CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic quantification of neurochemical markers of serotonin, dopamine and opioid systems in rat brain mesolimbic regions following chronic St John's wort treatment.
Chen F; Rezvani AH; Lawrence AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):126-33. PubMed ID: 12595953
[TBL] [Abstract][Full Text] [Related]
15. Herbal Medicine: Is it an Alternative or an Unknown? A Brief Review of Popular Herbals Used by Patients in a Pain and Symptom Management Practice Setting.
Leak JA
Curr Rev Pain; 1999; 3(3):226-236. PubMed ID: 10998678
[TBL] [Abstract][Full Text] [Related]
16. In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract.
Cott JM
Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():108-12. PubMed ID: 9342770
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term administration of hypericum extracts on the affinity and density of the central serotonergic 5-HT1 A and 5-HT2 A receptors.
Teufel-Mayer R; Gleitz J
Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():113-6. PubMed ID: 9342771
[TBL] [Abstract][Full Text] [Related]
18. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.
Müller WE; Rolli M; Schäfer C; Hafner U
Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():102-7. PubMed ID: 9342769
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of MAO and COMT by hypericum extracts and hypericin.
Thiede HM; Walper A
J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S54-6. PubMed ID: 7857510
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
